Cardiol Therapeutics to Webcast Annual Shareholder Meeting
Ticker: CRDL · Form: 6-K · Filed: May 27, 2025 · CIK: 1702123
Sentiment: neutral
Topics: shareholder-meeting, webcast, filing-update
Related Tickers: CRDL
TL;DR
Cardiol Therapeutics (CRDL) holding virtual shareholder meeting tomorrow, May 28th, 4:30 PM EDT. Tune in!
AI Summary
Cardiol Therapeutics Inc. announced on May 27, 2025, that it will webcast its Virtual Annual General Meeting of Shareholders on May 28, 2025, at 4:30 p.m. EDT. This filing is a Form 6-K report submitted to the SEC.
Why It Matters
Shareholders can virtually attend and participate in the company's annual general meeting, providing transparency and engagement opportunities.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting webcast and does not contain significant financial or operational news.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Registrant
- May 27, 2025 (date) — News Release Date
- May 28, 2025 (date) — Meeting Date
- 4:30 p.m. EDT (time) — Meeting Time
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing is to report a news release dated May 27, 2025, announcing that Cardiol Therapeutics will webcast its Virtual Annual General Meeting of Shareholders on May 28, 2025.
When and at what time will the Virtual Annual General Meeting of Shareholders be webcast?
The meeting will be webcast on May 28, 2025, at 4:30 p.m. EDT.
What is the company's principal executive office address?
The company's principal executive offices are located at 602-2265 Upper Middle Road East, Oakville, Ontario, Canada L6H 0G5.
Which form does Cardiol Therapeutics file annual reports under?
Cardiol Therapeutics files annual reports under Form 40-F.
What is the Commission File Number for Cardiol Therapeutics?
The Commission File Number for Cardiol Therapeutics is 001-40712.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 27, 2025 regarding Cardiol Therapeutics Inc. (CRDL).